Cargando…

Effects of Levocarnitine Treatment on the Cardiac Function in Hemodialysis Patients

Detalles Bibliográficos
Autores principales:	Maruyama, Takashi, Abe, Masanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355415/ https://www.ncbi.nlm.nih.gov/pubmed/30146610 http://dx.doi.org/10.2169/internalmedicine.1575-18

Ejemplares similares

Significance of Levocarnitine Treatment in Dialysis Patients
por: Takashima, Hiroyuki, et al.
Publicado: (2021)

Effects of Levocarnitine on Brachial-Ankle Pulse Wave Velocity in Hemodialysis Patients: A Randomized Controlled Trial
por: Higuchi, Terumi, et al.
Publicado: (2014)

High-Flux Hemodialysis and Levocarnitine in the Treatment of Severe Valproic Acid Intoxication
por: Temel, V., et al.
Publicado: (2013)

Effect of levocarnitine administration in patients with chronic liver disease
por: Ohashi, Kazuki, et al.
Publicado: (2020)

The Efficacy of Levocarnitine Treatment in Relieving Fatigue in Patients with Cirrhosis but without Overt Hepatic Encephalopathy
por: Abe, Kazumichi, et al.
Publicado: (2021)

Association between Levocarnitine Treatment and the Change in Knee Extensor Strength in Patients Undergoing Hemodialysis: A Post-Hoc Analysis of the Osaka Dialysis Complication Study (ODCS)
por: Matsufuji, Shota, et al.
Publicado: (2022)

Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis
por: Hiramatsu, Akira, et al.
Publicado: (2019)

Long-Term Levocarnitine Ameliorates Left Ventricular Diastolic as Well as Systolic Dysfunction in Hemodialysis Patients　― Multi-Center Study ―
por: Naito, Junko, et al.
Publicado: (2019)

Skeletal muscle volume loss among liver cirrhosis patients receiving levocarnitine predicts poor prognosis
por: Fujita, Masashi, et al.
Publicado: (2020)

Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients
por: Graziano, F, et al.
Publicado: (2002)

MON-065 Prevention of 6-Mercaptopurine-Induced Hypoglycemia by Levocarnitine Replacement
por: Torchinsky, Michael Yuri, et al.
Publicado: (2020)

Levocarnitine for valproate-induced hyperammonemia in the psychiatric setting: A case series and literature review
por: Brown, Lauren M., et al.
Publicado: (2018)

Levocarnitine for pegaspargase‐induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia
por: Schulte, Rachael, et al.
Publicado: (2021)

Effect of Levocarnitine vs Placebo as an Adjunctive Treatment for Septic Shock: The Rapid Administration of Carnitine in Sepsis (RACE) Randomized Clinical Trial
por: Jones, Alan E., et al.
Publicado: (2018)

A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders
por: Geier, David A., et al.
Publicado: (2011)

Topical Delivery of Levocarnitine to the Cornea and Anterior Eye by Thermosensitive in-situ Gel for Dry Eye Disease
por: Ma, Baorui, et al.
Publicado: (2021)

Levocarnitine regulates the growth of angiotensin II-induced myocardial fibrosis cells via TIMP-1
por: Shu, Jin, et al.
Publicado: (2023)

The effect of levocarnitine supplementation on dialysis-related hypotension: A systematic review, meta-analysis, and trial sequential analysis
por: Chewcharat, Api, et al.
Publicado: (2022)

Spironolactone and Cardiac Arrhythmias in Hemodialysis Patients: Helpful or Harmful?
por: Pun, Patrick H.
Publicado: (2023)

Levocarnitine Supplementation Suppresses Lenvatinib-Related Sarcopenia in Hepatocellular Carcinoma Patients: Results of a Propensity Score Analysis
por: Okubo, Hironao, et al.
Publicado: (2021)

Effect of Levocarnitine on the Therapeutic Efficacy of Conventional Therapy in Children with Dilated Cardiomyopathy: Results of a Randomized Trial in 29 Children
por: Wang, Yuwen, et al.
Publicado: (2018)

Therapeutic Effects of Levocarnitine or Vitamin B Complex and E With Selenium on Glycerin-Treated Holstein Friesian Cows With Clinical Ketosis
por: Ha, Seungmin, et al.
Publicado: (2021)

Levocarnitine Improves AlCl(3)-Induced Spatial Working Memory Impairment in Swiss albino Mice
por: Al-Amin, Md. Mamun, et al.
Publicado: (2019)

Prevalence of Zinc Deficiency in Japanese Patients on Peritoneal Dialysis: Comparative Study in Patients on Hemodialysis
por: Shimizu, Satoshi, et al.
Publicado: (2020)

Clinical effects of tanshinone IIA sodium sulfonate combined with trimetazidine and levocarnitine in the treatment of AVMC and its effects on serum TNF-α, IL-18 and IL-35
por: Xu, Pengliang, et al.
Publicado: (2018)

Kinetics of Glucoregulatory Peptide Hormones during Hemodialysis with Cellulose Triacetate and Polysulfone Dialyzers in Patients with Diabetes and End-Stage Kidney Disease
por: Takao, Nobuteru, et al.
Publicado: (2023)

Oral Zinc Supplementation Reduces the Erythropoietin Responsiveness Index in Patients on Hemodialysis
por: Kobayashi, Hiroki, et al.
Publicado: (2015)

Effect of hyperuricemia and treatment for hyperuricemia in Japanese hemodialysis patients: A cohort study
por: Sugano, Naoki, et al.
Publicado: (2019)

Optimal hemodialysis treatment for pediatric kidney failure patients
por: Ahn, Yo Han
Publicado: (2023)

Will Incremental Hemodialysis Preserve Residual Function and Improve Patient Survival?
por: Davenport, Andrew
Publicado: (2015)

Overhydration, Cardiac Function and Survival in Hemodialysis Patients
por: Onofriescu, Mihai, et al.
Publicado: (2015)

Levocarnitine Protects H9c2 Rat Cardiomyocytes from H(2)O(2)-induced Mitochondrial Dysfunction and Apoptosis
por: Mao, Cui-Ying, et al.
Publicado: (2014)

Vitamin C and functional iron deficiency anemia in hemodialysis()
por: Kim, Yong-Lim
Publicado: (2012)

Effect of high flow arteriovenous fistula on cardiac function in hemodialysis patients
por: Saleh, Mohamed Ayman, et al.
Publicado: (2018)

Geriatric assessment in elderly hemodialysis patients
por: Erken, Ertugrul
Publicado: (2019)

Resistance exercise: an effective strategy to reverse muscle wasting in hemodialysis patients?
por: Rhee, Connie M., et al.
Publicado: (2014)

Long-term effect of COVID-19 infection on hemodialysis patients: Should we follow hemodialysis patients more closely?
por: Demiray, Atalay, et al.
Publicado: (2021)

Therapy for HBV Infection in Hemodialysis Patients: Is it Possible?
por: Einollahi, Behzad
Publicado: (2012)

A biomarker, osteoprotegerin, in patients undergoing hemodialysis
por: Ko, Gang Jee
Publicado: (2013)

Options for intravenous iron supplementation in hemodialysis patients
por: Kong, Ji Yoon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_at0870p371s0p5b08gprtc5cun